BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 19878865)

  • 1. Edging toward new therapeutics with cyclin D1 Egl'ng on cancer.
    Dang CV
    Cancer Cell; 2009 Nov; 16(5):361-2. PubMed ID: 19878865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of cyclin D1 and breast tumorigenesis by the EglN2 prolyl hydroxylase.
    Zhang Q; Gu J; Li L; Liu J; Luo B; Cheung HW; Boehm JS; Ni M; Geisen C; Root DE; Polyak K; Brown M; Richardson AL; Hahn WC; Kaelin WG; Bommi-Reddy A
    Cancer Cell; 2009 Nov; 16(5):413-24. PubMed ID: 19878873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement for CDK4 kinase function in breast cancer.
    Yu Q; Sicinska E; Geng Y; Ahnström M; Zagozdzon A; Kong Y; Gardner H; Kiyokawa H; Harris LN; Stål O; Sicinski P
    Cancer Cell; 2006 Jan; 9(1):23-32. PubMed ID: 16413469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron chelation and 2-oxoglutarate-dependent dioxygenase inhibition suppress mantle cell lymphoma's cyclin D1.
    Babosova O; Kapralova K; Raskova Kafkova L; Korinek V; Divoky V; Prchal JT; Lanikova L
    J Cell Mol Med; 2019 Nov; 23(11):7785-7795. PubMed ID: 31517438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is Cyclin D1-CDK4 kinase a bona fide cancer target?
    Malumbres M; Barbacid M
    Cancer Cell; 2006 Jan; 9(1):2-4. PubMed ID: 16413464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 in breast cancer pathogenesis.
    Arnold A; Papanikolaou A
    J Clin Oncol; 2005 Jun; 23(18):4215-24. PubMed ID: 15961768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are all cancer genes equal?
    Bartek J; Lukas J
    Nature; 2001 Jun; 411(6841):1001-2. PubMed ID: 11429580
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclin D1 determines mitochondrial function in vivo.
    Sakamaki T; Casimiro MC; Ju X; Quong AA; Katiyar S; Liu M; Jiao X; Li A; Zhang X; Lu Y; Wang C; Byers S; Nicholson R; Link T; Shemluck M; Yang J; Fricke ST; Novikoff PM; Papanikolaou A; Arnold A; Albanese C; Pestell R
    Mol Cell Biol; 2006 Jul; 26(14):5449-69. PubMed ID: 16809779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin D1 genotype and breast cancer metastasis.
    Langsenlehner U; Hofmann G; Samonigg H; Krippl P; Renner W; Clar H
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1844-5. PubMed ID: 16030129
    [No Abstract]   [Full Text] [Related]  

  • 10. Prolyl hydroxylation by EglN2 destabilizes FOXO3a by blocking its interaction with the USP9x deubiquitinase.
    Zheng X; Zhai B; Koivunen P; Shin SJ; Lu G; Liu J; Geisen C; Chakraborty AA; Moslehi JJ; Smalley DM; Wei X; Chen X; Chen Z; Beres JM; Zhang J; Tsao JL; Brenner MC; Zhang Y; Fan C; DePinho RA; Paik J; Gygi SP; Kaelin WG; Zhang Q
    Genes Dev; 2014 Jul; 28(13):1429-44. PubMed ID: 24990963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of cytoplasmic cyclin D1 mutants.
    Murakami H; Horihata M; Andojo S; Yoneda-Kato N; Kato JY
    FEBS Lett; 2009 May; 583(10):1575-80. PubMed ID: 19409388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 gene amplification in proliferating haemangioma.
    Mohamed AM; Elwakil TF; Taher IM; Elbarbary MM; Kayed HF; Hussein HA; Eid OM
    Cell Tissue Res; 2009 Oct; 338(1):107-15. PubMed ID: 19823825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential specific breast cancer treatment uncovered in mouse experiments.
    Bradbury J
    Lancet; 2001 Jun; 357(9274):2109. PubMed ID: 11445115
    [No Abstract]   [Full Text] [Related]  

  • 14. Malignant melanoma with monster cells showing massive cyclin D1 amplification.
    Pouryazdanparast P; Newman M; Mafee M; Guitart J; Gerami P
    Am J Dermatopathol; 2009 Jun; 31(4):402-3. PubMed ID: 19461251
    [No Abstract]   [Full Text] [Related]  

  • 15. A novel l-isoleucine hydroxylating enzyme, l-isoleucine dioxygenase from Bacillus thuringiensis, produces (2S,3R,4S)-4-hydroxyisoleucine.
    Kodera T; Smirnov SV; Samsonova NN; Kozlov YI; Koyama R; Hibi M; Ogawa J; Yokozeki K; Shimizu S
    Biochem Biophys Res Commun; 2009 Dec; 390(3):506-10. PubMed ID: 19850012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
    Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
    Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of OxyE as an ancillary oxygenase during tetracycline biosynthesis.
    Wang P; Zhang W; Zhan J; Tang Y
    Chembiochem; 2009 Jun; 10(9):1544-50. PubMed ID: 19472250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alternative splicing, molecular diagnosis and breast cancer].
    Nau JY
    Rev Med Suisse; 2009 Mar; 5(196):696. PubMed ID: 19462616
    [No Abstract]   [Full Text] [Related]  

  • 19. New families of enantiopure cyclohexenone cis-diol, o-quinol dimer and hydrate metabolites from dioxygenase-catalysed dihydroxylation of phenols.
    Boyd DR; Sharma ND; Malone JF; Allen CC
    Chem Commun (Camb); 2009 Jun; (24):3633-5. PubMed ID: 19521632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FtmOx1, a non-heme Fe(II) and alpha-ketoglutarate-dependent dioxygenase, catalyses the endoperoxide formation of verruculogen in Aspergillus fumigatus.
    Steffan N; Grundmann A; Afiyatullov S; Ruan H; Li SM
    Org Biomol Chem; 2009 Oct; 7(19):4082-7. PubMed ID: 19763315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.